Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (4352)	7/15/1998 11:08:00 AM
From: Hunter Vann	Read Replies (2) \| Respond to of 9523

Received my American Century Ultra Semi-Annual report today. On page 7 they say, "The second best performing stock was Pfizer. This company continues to benefit from a dominant product pipeline, more predictable earnings and a strong balance sheet. A successful new product is Viagra, a treatment for impotence." Ultra has about 26 billion in Assets and a 1 year return of 39.75%. They currently have 3,099,000 shares of Pfizer for a value of $352,705,000.00, which is roughly about $113/share.